Campus, Baby Girl .
HRN: 27-24-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
06/17/2025
06/29/2025
IVTT
14mg As LD Then 8.4mg
Q48
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes